Idexx Laboratories's market cap is currently $51.53B. The company's EPS TTM is $3.63; its P/E ratio is 53.97; Idexx Laboratories is scheduled to report earnings on August 4, 2025, and the estimated EPS forecast is $3.13. See an overview of income statement, balance sheet, and cash flow financials.
